Savers Value Village insider: Option exercise and 10b5-1 sale detailed
Rhea-AI Filing Summary
Insider transactions by Savers Value Village, Inc. CEO Mark T. Walsh show that on 09/05/2025 he exercised previously granted options at an exercise price of $1.41 to acquire 5,650 shares and immediately sold 5,650 shares pursuant to a 10b5-1 plan at a weighted-average price of $13.00 (execution range $13.00–$13.03). Following these transactions, the reporting person’s direct beneficial ownership of common stock is reported as 0 shares. The form also discloses the reporting person holds options covering 2,108,806 underlying shares with a $1.41 exercise price; these options include approximately 37% time-based and 63% performance-based awards, with certain performance tranches tied to stock-price criteria.
Positive
- Sale executed under a 10b5-1 plan, indicating a pre-established trading arrangement for transparency and compliance
- Options previously granted have fully vested (October 7, 2019 grant fully vested by October 7, 2024), enabling orderly exercise
- Detailed disclosure of option composition (approx. 37% time-based, 63% performance-based) clarifies incentive structure
Negative
- Direct beneficial ownership reduced to 0 shares after the reported sale, which may concern some investors regarding insider holding levels
- Large potential dilution remains through options covering 2,108,806 underlying shares, subject to performance vesting
Insights
TL;DR: CEO exercised vested options and sold the acquired shares under a pre-established 10b5-1 plan, retaining a large options position tied to performance.
The transaction structure—exercise of options at $1.41 followed by an immediate sale under a 10b5-1 plan at a weighted-average price of $13.00—indicates liquidity-taking from option gains rather than an open-market, ad-hoc sale. The report shows 0 shares beneficially owned directly after the sale, while the executive continues to hold options on 2,108,806 underlying shares. The mix of ~37% time-based and ~63% performance-based options means future dilution and insider exposure remain contingent on performance criteria.
TL;DR: Use of a 10b5-1 plan and disclosure of option composition reflects procedural compliance and material insider holdings.
The filing discloses that the sale was executed pursuant to a 10b5-1 trading plan adopted May 19, 2025, which provides an affirmative defense against allegations of trading on material nonpublic information when properly adopted. The reporting highlights the vesting schedule history for the October 7, 2019 grant and specifies the performance-vesting component tied to IPO and stock-price metrics; this is useful for assessing alignment of executive incentives with shareholder outcomes.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option (Right to Purchase) | 5,650 | $1.41 | $8K |
| Exercise | Common Stock | 5,650 | $1.41 | $8K |
| Sale | Common Stock | 5,650 | $13.00 | $73K |
Footnotes (1)
- The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on May 19, 2025. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $13.00 to $13.03. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024. Approximately 37% represents time-based options which vested in substantially equal annual installments over five years starting October 7, 2020 and approximately 63% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.